Identification of miRNA-mediated core gene module for glioma patient prediction by integrating high-throughput miRNA, mRNA expression and pathway structure

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Zhang, Chunlong ^a   Li, Chunquan ^a   Li, Jing ^a,d   Han, Junwei ^a   Shang, Desi ^a   Zhang, Yunpeng ^a   Zhang, Wei ^b   Yao, Qianlan ^a   Han, Lei ^c   Xu, Yanjun ^a   Yan, Wei ^b   Bao, Zhaoshi ^b   You, Gan ^b   Jiang, Tao ^b   Kang, Chunsheng ^c   Li, Xia ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c TIANJIN MEDICAL UNIVERSITY   (China)

^d FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA;

ADULT; ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GLIOBLASTOMA; GLIOMA; HIGH THROUGHPUT SEQUENCING; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIOMA; OVERALL SURVIVAL; PREDICTION; SIGNAL TRANSDUCTION; SURVIVAL TIME; BIOLOGY; GENETICS; PATHOLOGY; PROCEDURES; PROGNOSIS; SURVIVAL; TUMOR GENE;

ADULT; COMPUTATIONAL BIOLOGY; FEMALE; GENE EXPRESSION PROFILING; GENES, NEOPLASM; GLIOMA; HUMANS; MALE; MICRORNAS; NEOPLASM GRADING; PROGNOSIS; RNA, MESSENGER; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS;

EID: 84901049591     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096908     Document Type: Article

References (51)

1. Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, et al. (2007) Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 21: 2683-2710. (Pubitemid 350070717)
2. Gladson CL, Prayson RA, Liu WM (2010) The pathobiology of glioma tumors. Annu Rev Pathol 5: 33-50.
3. (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455: 1061-1068.
4. He L, Hannon GJ (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5: 522-531. (Pubitemid 38868508)
5. Van der Auwera I, Limame R, van Dam P, Vermeulen PB, Dirix LY, et al. (2010) Integrated miRNA and mRNA expression profiling of the inflammatory breast cancer subtype. Br J Cancer 103: 532-541.
6. Zhu M, Yi M, Kim CH, Deng C, Li Y, et al. (2011) Integrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineage. Genome Biol 12: R77.
7. Dong H, Siu H, Luo L, Fang X, Jin L, et al. (2010) Investigation gene and microRNA expression in glioblastoma. BMC Genomics 11 Suppl 3: S16.
8. Dong H, Luo L, Hong S, Siu H, Xiao Y, et al. (2010) Integrated analysis of mutations, miRNA and mRNA expression in glioblastoma. BMC Syst Biol 4: 163.
9. Sun J, Gong X, Purow B, Zhao Z (2012) Uncovering MicroRNA and Transcription Factor Mediated Regulatory Networks in Glioblastoma. PLoS Comput Biol 8: e1002488.
10. Li X, Li C, Shang D, Li J, Han J, et al. (2011) The implications of relationships between human diseases and metabolic subpathways. PLoS One 6: e21131.
11. Li C, Shang D, Wang Y, Li J, Han J, et al. (2012) Characterizing the network of drugs and their affected metabolic subpathways. PLoS One 7: e47326.
12. Li X, Jiang W, Li W, Lian B, Wang S, et al. (2012) Dissection of human MiRNA regulatory influence to subpathway. Brief Bioinform 13: 175-186.
13. Kefas B, Comeau L, Floyd DH, Seleverstov O, Godlewski J, et al. (2009) The neuronal microRNA miR-326 acts in a feedback loop with notch and has therapeutic potential against brain tumors. J Neurosci 29: 15161-15168.
14. Kefas B, Comeau L, Erdle N, Montgomery E, Amos S, et al. (2010) Pyruvate kinase M2 is a target of the tumor-suppressive microRNA-326 and regulates the survival of glioma cells. Neuro Oncol 12: 1102-1112.
15. Zhang CZ, Zhang JX, Zhang AL, Shi ZD, Han L, et al. (2010) MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma. Mol Cancer 9: 229.
16. Freije WA, Castro-Vargas FE, Fang Z, Horvath S, Cloughesy T, et al. (2004) Gene expression profiling of gliomas strongly predicts survival. Cancer Res 64: 6503-6510. (Pubitemid 39297907)
17. Srinivasan S, Patric IR, Somasundaram K (2011) A ten-microRNA expression signature predicts survival in glioblastoma. PLoS One 6: e17438.
18. Zhang W, Zhang J, Yan W, You G, Bao Z, et al. (2012) Whole-genome microRNA expression profiling identifies a 5-microRNA signature as a prognostic biomarker in Chinese patients with primary glioblastoma multiforme. Cancer.
19. Zhang JX, Zhang J, Yan W, Wang YY, Han L, et al. (2013) Unique genome-wide map of TCF4 and STAT3 targets using ChIP-seq reveals their association with new molecular subtypes of glioblastoma. Neuro Oncol 15: 279-289.
20. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, et al. (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9: 157-173. (Pubitemid 43357943)
21. Murat A, Migliavacca E, Gorlia T, Lambiv WL, Shay T, et al. (2008) Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. J Clin Oncol 26: 3015-3024.
22. Lee Y, Scheck AC, Cloughesy TF, Lai A, Dong J, et al. (2008) Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age. BMC Med Genomics 1: 52.
23. Edgar R, Domrachev M, Lash AE (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207-210. (Pubitemid 34679544)
24. Maragkakis M, Reczko M, Simossis VA, Alexiou P, Papadopoulos GL, et al. (2009) DIANA-microT web server: elucidating microRNA functions through target prediction. Nucleic Acids Res 37: W273-276.
25. Betel D, Koppal A, Agius P, Sander C, Leslie C (2010) Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol 11: R90.
26. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, et al. (2005) Combinatorial microRNA target predictions. Nat Genet 37: 495-500. (Pubitemid 40617277)
27. Miranda KC, Huynh T, Tay Y, Ang YS, Tam WL, et al. (2006) A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 126: 1203-1217. (Pubitemid 44380294)
28. Rehmsmeier M, Steffen P, Hochsmann M, Giegerich R (2004) Fast and effective prediction of microRNA/target duplexes. RNA 10: 1507-1517. (Pubitemid 39288185)
29. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20. (Pubitemid 40094598)
30. Kertesz M, Iovino N, Unnerstall U, Gaul U, Segal E (2007) The role of site accessibility in microRNA target recognition. Nat Genet 39: 1278-1284. (Pubitemid 47482690)
31. Wang X (2008) miRDB: a microRNA target prediction and functional annotation database with a wiki interface. RNA 14: 1012-1017.
32. Bandyopadhyay S, Mitra R (2009) TargetMiner: microRNA target prediction with systematic identification of tissue-specific negative examples. Bioinformatics 25: 2625-2631.
33. Enright AJ, John B, Gaul U, Tuschl T, Sander C, et al. (2003) MicroRNA targets in Drosophila. Genome Biol 5: R1.
34. Papadopoulos GL, Reczko M, Simossis VA, Sethupathy P, Hatzigeorgiou AG (2009) The database of experimentally supported targets: a functional update of TarBase. Nucleic Acids Res 37: D155-158.
35. Xiao F, Zuo Z, Cai G, Kang S, Gao X, et al. (2009) miRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Res 37: D105-110.
36. Kanehisa M, Goto S (2000) KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28: 27-30. (Pubitemid 30047706)
37. Li C, Li X, Miao Y, Wang Q, Jiang W, et al. (2009) SubpathwayMiner: a software package for flexible identification of pathways. Nucleic Acids Res 37: e131.
38. Li C, Han J, Yao Q, Zou C, Xu Y, et al. (2013) Subpathway-GM: identification of metabolic subpathways via joint power of interesting genes and metabolites and their topologies within pathways. Nucleic Acids Res 41: e101.
39. Yu J, Cordero KE, Johnson MD, Ghosh D, Rae JM, et al. (2008) A transcriptional fingerprint of estrogen in human breast cancer predicts patient survival. Neoplasia 10: 79-88. (Pubitemid 351170715)
40. Naderi A, Teschendorff AE, Barbosa-Morais NL, Pinder SE, Green AR, et al. (2007) A gene-expression signature to predict survival in breast cancer across independent data sets. Oncogene 26: 1507-1516. (Pubitemid 46340809)
41. Kohler S, Bauer S, Horn D, Robinson PN (2008) Walking the interactome for prioritization of candidate disease genes. Am J Hum Genet 82: 949-958.
42. Malzkorn B, Wolter M, Liesenberg F, Grzendowski M, Stuhler K, et al. (2010) Identification and functional characterization of microRNAs involved in the malignant progression of gliomas. Brain Pathol 20: 539-550.
43. Bonci D, Coppola V, Musumeci M, Addario A, Giuffrida R, et al. (2008) The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med 14: 1271-1277.
44. Bhattacharya R, Nicoloso M, Arvizo R, Wang E, Cortez A, et al. (2009) MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer. Cancer Res 69: 9090-9095.
45. Gao L, Li F, Dong B, Zhang J, Rao Y, et al. (2010) Inhibition of STAT3 and ErbB2 suppresses tumor growth, enhances radiosensitivity, and induces mitochondria-dependent apoptosis in glioma cells. Int J Radiat Oncol Biol Phys 77: 1223-1231.
46. Kim JH, Zheng LT, Lee WH, Suk K (2011) Pro-apoptotic role of integrin beta3 in glioma cells. J Neurochem 117: 494-503.
47. Khalil AA, Jameson MJ, Broaddus WC, Lin PS, Chung TD (2012) Nicotine enhances proliferation, migration, and radioresistance of human malignant glioma cells through EGFR activation. Brain Tumor Pathol.
48. Chen L, Zhang J, Feng Y, Li R, Sun X, et al. (2012) MiR-410 regulates MET to influence the proliferation and invasion of glioma. Int J Biochem Cell Biol 44: 1711-1717.
49. Parsons JT (2003) Focal adhesion kinase: the first ten years. J Cell Sci 116: 1409-1416.
50. Dobbin K, Simon R (2005) Sample size determination in microarray experiments for class comparison and prognostic classification. Biostatistics 6: 27-38. (Pubitemid 41240367)
51. Wen PY, Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359: 492-507.